Evidence map›Paper›PMID 40097329›Full record

ArticleClinical and translational medicine2025

Single-cell RNA sequencing of peripheral blood mononuclear cells from bronchopulmonary dysplasia.

Yufeng Liu, Chun Yan, Yushan Li, Ruoxing Zhou, Xiaoyu Lin, Qiong Meng, Sitao Li, Limei Zhong, Yanfang Tan, Wangkai Liu

Abstract read
In one paragraph

Article in Clinical and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yufeng LiuCenter for Medical Research on Innovation and Translation, Guangzhou First People's Hospital, the Second Affiliated Hospital of South China University of Technology, Guangzhou, China.ORCID 0009-0002-4794-3316
Chun YanCenter for Medical Research on Innovation and Translation, Guangzhou First People's Hospital, the Second Affiliated Hospital of South China University of Technology, Guangzhou, China.
Yushan LiDepartment of Pediatrics, Guangdong Women and Children Hospital, Guangzhou, China.
Ruoxing ZhouCenter for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Xiaoyu LinDepartment of Pediatrics, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Qiong MengDepartment of Pediatrics, The Second People's Hospital of Guangdong Province, Guangzhou, China.
Sitao LiDepartment of Pediatrics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Limei ZhongDepartment of Laboratory Medicine, Guangdong Second Provincial General Hospital, Guangzhou, China.
Yanfang TanDepartment of Pediatrics, Guangdong Women and Children Hospital, Guangzhou, China.
Wangkai LiuDepartment of Pediatrics, Guangdong Women and Children Hospital, Guangzhou, China.

Funding

Basic and Applied Basic Research Fund of Guangdong Province 2022A1515012548National Natural Science Funds 82171695Natural Science Foundation of Guangdong Province, China 2022A1515010031Science and Technology Program of Guangzhou SL2024A03J01319Science and Technology Program of Guangzhou SL2024A04J00240
6 · The paper itself

Abstract

backgroundBronchopulmonary dysplasia (BPD) is a severe respiratory disease that primarily affects premature infants, characterized by persistent inflammation and abnormal immune activation. This study aimed to elucidate the immunological mechanisms underlying BPD by integrating single-cell RNA sequencing with T/B cell receptor profiling of peripheral blood mononuclear cells (PBMCs) from preterm infants with BPD, complemented by validation in a murine BPD model.

methodsWe profiled PBMCs from preterm infants diagnosed with BPD and healthy controls, identifying 22 distinct cell clusters corresponding to major immune cell types.

resultsSignificant alterations were observed in myeloid and lymphoid subsets, with neutrophils undergoing metabolic reprogramming toward oxidative phosphorylation. T and B cell subsets exhibited phenotypic and functional changes, with B cells serving as crucial interaction hubs in cell communication networks. Progenitor cell analysis in BPD mouse models revealed specific alterations in hematopoietic stem cells. Analysis of cell-cell communication networks highlighted intricate intercellular interactions in BPD, emphasizing a pivotal role for the BTLA-TNFRSF14 signaling axis in disease pathogenesis. Additionally, pharmacological blockade of BTLA in mouse models alleviated disease severity, suggesting its potential therapeutic effects through modulation of the BTLA-TNFRSF14 pathway.

conclusionThese findings enhance the understanding of the BPD immune microenvironment and lay the foundation for developing targeted immunomodulatory therapies. HIGHLIGHTS: Single-cell sequencing revealed immune cell profiles in bronchopulmonary dysplasia (BPD). Neutrophils underwent metabolic changes, and B cells were key in immune communication. Targeting B and T lymphocyte attenuator (BTLA)-TNFRSF14 signalling reduced BPD severity in mouse models, suggesting a potential therapy.

Indexed as

Bronchopulmonary DysplasiaLeukocytes, MononuclearSequence Analysis, RNASingle-Cell AnalysisAnimalsDisease Models, AnimalFemaleHumansInfant, NewbornInfant, PrematureMaleMice

Identifiers

PMID40097329
PMCPMC11913593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.